Home・Lista de Ações・AxoGen Inc

AxoGen Inc

Fechado

SetorSaúde

49.94 8.14

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

49.7

Máximo

50.58

Indicadores-chave
By Trading Economics
Rendimento	18M -1.5M
Vendas	8.3M 70M
EPS	-0.03
Margem de lucro	-2.174
Funcionários	622
EBITDA	15M -2.2M

Recomendações
By TipRanks
Recomendações	Compra Forte
Previsão para 12 meses	+9.46% upside

Dividendos
By Acuity
Próximos Ganhos	28 de out. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	455M 2.6B
Abertura anterior	41.8
Fecho anterior	49.94

Sentimento de Notícias

By Acuity

67%

33%

307 / 340 Ranking em Healthcare

AxoGen Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

21 de ago. de 2026, 20:01 UTC

AxoGen Inc shares are higher today, supported by high trading volume. The stock remains above its 20-day moving average amid broader market gains.

20 de ago. de 2026, 22:46 UTC

AxoGen Inc shares are higher in after-market trading, showing notable strength above the 20-day moving average and near the upper end of its one-month range.

19 de ago. de 2026, 21:01 UTC

AxoGen Inc shares are lower in after-market trading, despite no specific news to explain the decline. The stock remains near its one-month high.

18 de ago. de 2026, 19:16 UTC

AxoGen Inc shares are higher, continuing positive momentum from Monday. The stock remains above its 20-day moving average, reflecting strong performance.

17 de ago. de 2026, 21:01 UTC

AxoGen Inc shares are higher in after-market trading, reaching a peak above Monday's close amid broader market pressures and rising crude oil prices.

14 de ago. de 2026, 20:06 UTC

AxoGen Inc's shares are higher today amid mixed market sentiment following a decline in U.S. retail sales for July. No specific company news was identified.

13 de ago. de 2026, 22:36 UTC

AxoGen Inc. shares declined in after-market trading, despite broader market strength and earlier gains. The stock remains above recent performance averages.

12 de ago. de 2026, 19:32 UTC

AxoGen Inc shares are higher today amid strong trading volume and broader market gains, reflecting optimism from recent inflation data.

10 de ago. de 2026, 19:41 UTC

AxoGen Inc shares are higher, driven by gains in the Health Care Equipment sub-sector and unusually high market volume. The stock remains above its 20-day moving average.

7 de ago. de 2026, 20:05 UTC

AxoGen Inc shares are higher today amid strong market volume, reflecting a broader upward trend since Thursday's close.

5 de ago. de 2026, 19:46 UTC

AxoGen Inc shares are lower amid broader market caution following ADP's report of a significant miss in private sector job growth for July.

4 de ago. de 2026, 20:06 UTC

AxoGen Inc's shares are higher today, continuing a steady climb since Monday's close amid positive market sentiment and broader trends.

3 de ago. de 2026, 20:02 UTC

News

AxoGen Inc. shares are advancing as trading volume spikes amid strong interest. The company reported a 23.1% revenue increase to $69.7 million for Q2 2026.

31 de jul. de 2026, 20:06 UTC

AxoGen Inc shares are higher, recovering from an earlier dip. The stock remains above its 20-day moving average, reflecting solid overall performance.

30 de jul. de 2026, 19:24 UTC

AxoGen Inc shares are higher, supported by significant broader market gains and unusually high trading volume, despite earlier pulling back from session highs.

29 de jul. de 2026, 20:41 UTC

AxoGen Inc shares are lower in after-market trading amid a broader downturn in U.S. equities and rising crude oil prices linked to geopolitical tensions.

28 de jul. de 2026, 20:03 UTC

AxoGen Inc. shares are declining today, pulling back from an earlier high amid broader market weakness linked to declines in Asian indices.

27 de jul. de 2026, 19:16 UTC

AxoGen Inc shares are higher today, continuing a strong upward trend since Friday's close. Broader market sentiment is influenced by declining oil prices.

22 de jul. de 2026, 20:01 UTC

AxoGen Inc shares are lower in Wednesday's session amid high trading volume, continuing a decline that began Tuesday. No specific news was identified.

21 de jul. de 2026, 17:46 UTC

AxoGen Inc shares are higher today, having earlier peaked around 3.01% before pulling back. No specific news was identified to explain the movement.

20 de jul. de 2026, 19:06 UTC

AxoGen Inc. shares are lower during Monday's session, pulling back from earlier highs amid rising Treasury yields and inflation concerns linked to oil prices.

Comparação entre Pares

Variação de preço

AxoGen Inc Previsão

Preço-alvo

By TipRanks

9.46% parte superior

Previsão para 12 meses

Média 55.17 USD 9.46%

Máximo 58 USD

Mínimo 53 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para AxoGen Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

6 ratings

Comprar

Manter

Vender

Com base em 6 analistas que deram avaliações de ações para AxoGen Inc - Dist nos últimos 3 meses.

Sentimento

By Acuity

307 / 340 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre AxoGen Inc

Axogen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. Axogen, Inc. is headquartered in Alachua, Florida.